Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by mattw1100on Sep 12, 2019 4:04pm

201 Views

Post# 30121283

RE:RE:RE:RE:RE:RE:RE:RE:RE:Market Perception Changing?

Another strong day on moderate (low) volume for TH standards. Interesting 29K sitting on the bid at 5.53 appeared around 3:45 today. Approaching some ristance @ 5.70 however if we have EU approval or other positive news we could blow through that easily. Otherwise would expect some consolidation/retrace around $5.70.

Bullboard Posts

10 best-performing AI stocks for Canadian investors